Skip to main content

Table 2 Descriptive characteristics of the explorative measurements at baseline

From: A randomized controlled trial on a multicomponent intervention for overweight school-aged children – Copenhagen, Denmark

   Control group Intervention group P value
  n Baseline Baseline  
Glycemic control     
  HbA1c (mmol/mol) 30 34.9 (2.8) 34.9 (2.5) 1.0
  Oral glucose tolerance test     
   Fasting glucose (mmol/L) 30 4.3 (0.2) 4.4 (0.3) 0.2
   Fasting insulin (mmol/L) 30 62.9 (38.5) 67.7 (25.4) 0.7
   120 min (2 h) glucose (mmol/L) 26 5.7 (1.1) 5.6 (0.8) 0.8
   Matsuda Index 25 21.8 (12.4) 13.0 (3.9) P <0.05
   HOMA-IR 30 1.7 (1.1) 1.9 (0.7) 0.6
  Mean 48 h BG (mmol/L) by CGMS 19 4.8 (0.4) 5.3 (0.6) P <0.05
Biochemistry     
  Alanintransaminase (U/l) 29 30.1 (21.2) 26.8 (11.1) 0.6
  Aspartattransaminase (U/l) 29 33.0 (12.2) 31.4 (5.2) 0.7
  Thyrotropin (x10-3int.enh./l) 30 2.6 (1.2) 2.7 (0.9) 0.6
  Triiodthyronin (nmol/l) 30 2.8 (0.5) 2.6 (0.3) 0.3
  Thyroxin (nmol/l) 30 107.1 (26.8) 102.1 (18.9) 0.6
  Total cholesterol (mmol/L) 30 4.6 (0.6) 4.3 (0.9) 0.5
  LDL (mmol/L) 30 2.7 (0.4) 2.7 (0.8) 0.9
  HDL (mmol/L) 30 1.5 (0.4) 1.4 (0.4) 0.5
  Triglycerides (mmol/L) 30 0.9 (0.8) 0.7 (0.2) 0.4
  Estradiol (pmol/L)# 29 35 (30) 28 (14) 0.05
  Testosterone (nmol/L)# 28 0.12 (0.0) 0.12 (0.0) 0.9
  Sex hormone-binding globulin (nmol/L)# 29 62 (37) 49 (33) 0.4
  Follicle-stimulating hormone (IU/L)# 29 1.11 (1.33) 1.06 (0.81) 0.9
  Luteinizing hormone (IU/L)# 29 0.03 (0.12) 0.03 (0.04) 0.4
  IGFBP-3 (ng/mL)# 29 4080 (1130) 4695 (490) 0.06
  Insulin-like growth factor 1 (ng/mL)# 29 229 (131) 244.5 (74) 0.6
  Adiponectin (ng/mL)# 26 19,547 (8,790) 18,138 (5,740) 0.5
  Leptin (pg/mL)# 25 17,613 (27,432) 26,399 (23,333) 0.3
  Resistin (ng/mL)# 26 7.0 (2.5) 7.5 (2.1) 0.3
  Visfatin (ng/mL)# 23 0.34 (0.49) 0.39 (0.62) 0.9
  1. Presented as mean (standard deviation) and P value assessed by unpaired Student’s t-test, or #median (interquartile range) and P value assessed by Wilcoxon rank-sum test.
  2. Mean 48 h BG by CGMS, mean blood glucose measured in 48 h by continuous glucose monitoring system.
  3. HbA1c, glycosylated hemoglobin; HDL, high-density lipoprotein; LDL, low-density lipoprotein.
  4. IGFBP-3, Insulin-like growth factor-binding protein 3.